Loading
NASDAQHealthcareMedical - Devices
Latest quote
$424.06
−$14.095 · -3.22%
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Regular session
$424.06
−$14.095 · -3.22%
Regular session · ET · Market data may be delayed.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Day range
Current $424.06
52-week range
Current $424.06
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
20
Overpriced
Sentiment
50
Mixed
Risk
48
Elevated Risk
Momentum
54
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Day range
Current $424.06
52-week range
Current $424.06
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.44B USD | 3.37B USD | 2.96B USD | 2.53B USD | 2.42B USD |
| Cost of goods sold | 1.86B USD | 1.72B USD | 1.45B USD | 1.23B USD | 1.21B USD |
| Gross profit | 1.58B USD | 1.65B USD | 1.51B USD | 1.31B USD | 1.21B USD |
| Research and development | 395.2M USD | 376.5M USD | 294.8M USD | 235.9M USD | 220.8M USD |
| Selling, general, and administrative | 946.5M USD | 893.8M USD | 729.4M USD | 607.4M USD | 562.3M USD |
| Operating expenses | 1.34B USD | 1.4B USD | 1.08B USD | 873M USD | 796.3M USD |
| Interest income | 14.8M USD | 9.3M USD | 7.5M USD | 2.8M USD | 900K USD |
| Interest expense | 60.3M USD | 47.9M USD | 16.4M USD | 16.1M USD | 14.3M USD |
| Depreciation and amortization | 220.3M USD | 183.8M USD | 114.9M USD | 88.7M USD | 89.1M USD |
| Operating income | 236M USD | 253.1M USD | 436.9M USD | 432.7M USD | 413.3M USD |
| Net income | −8.6M USD | 113.1M USD | 427.2M USD | 296.6M USD | 277.1M USD |
Company facts updated Oct 8, 2026.
Recent quarterly results
Recent quarterly results
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Aug 14, 2026 | $3.984Quarterly | Aug 15, 2026 | Sep 1, 2026 |
Dividend | May 15, 2026 | $3.988Quarterly | May 15, 2026 | Jun 1, 2026 |
Dividend | Feb 13, 2026 | $3.984Quarterly | Feb 15, 2026 | Mar 2, 2026 |
Dividend | Nov 14, 2025 | $3.675Quarterly | Nov 15, 2025 | Dec 1, 2025 |
Ex-dividend Aug 14, 2026
$3.984
Quarterly
Record Aug 15, 2026 · Payment Sep 1, 2026
Ex-dividend May 15, 2026
$3.988
Quarterly
Record May 15, 2026 · Payment Jun 1, 2026
Ex-dividend Feb 13, 2026
$3.984
Quarterly
Record Feb 15, 2026 · Payment Mar 2, 2026
Ex-dividend Nov 14, 2025
$3.675
Quarterly
Record Nov 15, 2025 · Payment Dec 1, 2025
Funds reporting this stock among their holdings, ordered by reported position size.
iShares Preferred and Income Securities ETFPFF72.93M0.60%12.27B USD0.45%$29.265-0.36%
VanEck Preferred Securities ex Financials ETFPFXF31.02M1.31%2.36B USD0.40%$17.5601-0.73%
State Street SPDR Bloomberg Convertible Securities ETFCWB14.26M0.25%5.6B USD0.40%$100.37-1.02%
First Trust SSI Strategic Convertible Securities ETFFCVT506.35K0.52%97.7M USD0.95%$48.81-1.14%
iShares Morningstar Multi-Asset Income ETFIYLD113.87K0.09%124.74M USD0.50%$21.535-0.25%iShares Preferred and Income Securities ETFPFFVanEck Preferred Securities ex Financials ETFPFXFState Street SPDR Bloomberg Convertible Securities ETFCWBFirst Trust SSI Strategic Convertible Securities ETFFCVTiShares Morningstar Multi-Asset Income ETFIYLDAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
